Celltrion receives FDA Phase 1 IND approval for next-generation ADC drug ‘CT-P70’

Enhertu recommended for approval in the EU by CHMP for patients with HER2-low or HER2-ultralow...

Callio Therapeutics launches with US$187 Million series A to advance multi-payload ADC platform through clinical...

ENHERTU demonstrated statistically significant and clinically meaningful improvement in overall survival in patients with HER2...

SOTIO unveils promising preclinical data on SOT109, a next-gen ADC targeting Cadherin-17 (CDH17) for colorectal...

PinoBio announces results of dual-payload ADC platform research